Comparing two treatments for T3 rectal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial compares two treatment approaches for stage II (T3) rectal cancer: chemoradiation before surgery versus a total neoadjuvant therapy approach (chemotherapy and radiation) before surgery. It aims to find which is more effective and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with T3 rectal cancer that has not spread to lymph nodes or other organs.
- Your tumor can be surgically removed.
- You are 18 years or older.
- You have not had chemotherapy or radiation to the pelvis before.
- You are generally healthy enough for treatment, with good kidney, liver, and blood cell function.
- You are able to swallow pills and do not have serious heart or lung problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a full course of chemotherapy and radiation before any surgery (called total neoadjuvant therapy) can help you avoid surgery and preserve your rectum. It is for people with a specific early stage of rectal cancer that has not spread.
This Phase 2 study tests a “total neoadjuvant” approach, meaning you receive cancer treatment before surgery, to improve safety and effectiveness for rectal cancer. It may help by shrinking the tumor and planning a more effective operation, while researchers carefully track side effects.
This trial compares two approaches for early-stage rectal cancer: chemotherapy plus local surgery versus standard chemoradiotherapy. It aims to see if less intensive treatment can work just as well, reducing side effects.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial tests a new way of giving radiation and chemotherapy before surgery for rectal cancer that hasn't spread. It aims to see if this 'sandwich' approach is safe and works better than standard treatment.
This Phase 3 trial compares different chemotherapy and radiation combinations given before surgery for locally advanced rectal cancer, to see which one works better. It may help people get a tumor removed completely (R0 resection) and improve outcomes while comparing treatment safety and effectiveness.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.